- Disease
- Monday, 13 Apr 2020
The UK finance minister warns economy could shrink by 30% because of the coronavirus lockdown
Britain’s finance minister has told colleagues the economy could shrink by up to 30% this quarter because of the coronavirus lockdown, a newspaper reported, as the soaring death toll gave little hope restrictions would soon be lifted.
The number of COVID-19 deaths in hospitals across the United Kingdom has passed 10,000 and a senior scientific adviser to the government has said the country risked becoming the worst-hit in Europe.
The government has had to defend its response to the outbreak, with complaints of insufficient testing, a dearth of protective kit for medics and questions about whether Prime Minister Boris Johnson was too slow to impose a lockdown.
Johnson was starting his convalescence from the disease at his country residence on Monday after leaving hospital the previous day, with no clarity on when he would return to work.
In a deeply personal video message posted on Twitter shortly after he was discharged from St Thomas’ Hospital, where he had spent a week including three nights in intensive care, Johnson said “things could have gone either way” for him.
He thanked the public for adhering to strict social distancing measures, saying their efforts were worth it and had created a “human shield” around the state-run health service by reducing the spread of the new coronavirus.
While there was widespread sympathy for Johnson across the political spectrum over his illness, the upbeat tone of his message could not disguise the gravity of the choices now facing his government while he is away from his desk.
With foreign minister Dominic Raab deputising for him, but without the full authority of a prime minister, the government faced excruciating trade-offs between the needs of the health service and of the economy, with national morale also at stake.
Related Industry Updates
Homocystinuria Metabolic Disorder: Symptoms and Diagnosis Care Expand
Feb 16, 2026
Coronavirus in China Sent a Ripple of Risk Aversion Through Markets
Jan 21, 2020
Rare Neurological Disease Treatment Market Growth Insights to 2027 - Allergan, Bayer AG, GlaxoSmithKline, Johnson & Johnson Services
Apr 30, 2020
Coronavirus on G20 agenda as China reports uptick in cases
Feb 21, 2020
Taiho Oncology Announces Presentation of Data for Futibatinib in Advanced Intrahepatic Cholangiocarcinoma at 2020 ASCO Meeting
Jun 01, 2020
Oil Plunges as U.S. bans travel from Europe after WHO's Pandemic Declaration
Mar 12, 2020
Top Human Capital Trends Fueling Workplace Innovation
May 20, 2020